Andreas Norlin

Andreas Norlin

Chief Tech/Sci/R&D Officer at ASCELIA PHARMA AB

Net worth: 12 367 $ as of 31/05/2024

54 year
Health Technology
Consumer Services
Technology Services

Profile

Andreas L.
Norlin
is the founder of Xkout Bioscience AB.
He is currently working as a Director at ApoGlyx AB and Desupervised ApS.
Additionally, he is serving as the Chief Scientific Officer at Ascelia Pharma AB since 2020.
Dr. Norlin has a graduate and doctorate degree from the University of Lund.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
13/07/2023 12,364 ( 0.04% ) 12 367 $ 31/05/2024

Andreas Norlin active positions

CompaniesPositionStart
ASCELIA PHARMA AB Chief Tech/Sci/R&D Officer 01/01/2020
Director/Board Member -
Director/Board Member -
All active positions of Andreas Norlin

Former positions of Andreas Norlin

CompaniesPositionEnd
Xkout Bioscience AB Founder -
See the detail of Andreas Norlin's experience

Training of Andreas Norlin

University of Lund Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andreas Norlin's experience

Connections

18

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ASCELIA PHARMA AB

Health Technology

Private companies3

Health Technology

Xkout Bioscience AB

Technology Services

See company connections
  1. Stock Market
  2. Insiders
  3. Andreas Norlin